SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Clinical trial NCT07104331 · RECRUITING
Trial details
- NCT number
- NCT07104331
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-24
- Primary completion
- 2029-08-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.